Progress in brain delivery of Anti-HIV drugs

11Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The HIV/AIDS pandemic is an increasing global burden with devastating health-related and socioeconomic effects. The widespread use of antiretroviral therapy has dramatically improved life quality and expectancy of infected individuals. But currently available drug regimens and dosage forms are not good enough to eradicate HIV. Suboptimal adherence, toxicity, drug resistance and viral reservoirs make the lifelong treatment of HIV infection challenging. Along with some other organs, highly vascularized and secured with blood-brain barrier (BBB), brain acts as a great reservoir for the HIV virus. But all the available drug delivery techniques are not capable of bypassing the BBB and deliver anti-HIV drugs to the brain. In this review, all the brain delivery techniques available till date has been reviewed and recent noble ideas for delivering anti-HIV drugs to brain has been discussed.

Cite

CITATION STYLE

APA

Das, M. K., & Chakraborty, T. (2015). Progress in brain delivery of Anti-HIV drugs. Journal of Applied Pharmaceutical Science, 5(7), 154–164. https://doi.org/10.7324/JAPS.2015.50724

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free